Nanoelectrospray ionization mass spectrometric study of Mycobacterium tuberculosis CYP121-ligand interactions.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Analytical Chemistry

• Publication date

  2013-06-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/ac400236zPMID 23675886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121.

  2012cited by this paper
• Quantifying ligand binding to large protein complexes using electrospray ionization mass spectrometry.

  2012cited by this paper
• Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.

  2012cited by this paper
• Mass spectrometry based tools to investigate protein-ligand interactions for drug discovery.

  2012cited by this paper
• Applications of a catch and release electrospray ionization mass spectrometry assay for carbohydrate library screening.

  2012cited by this paper
• Studying protein–protein affinity and immobilized ligand–protein affinity interactions using MS-based methods

  2011cited by this paper
• Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis

  2011cited by this paper
• Quantifying labile protein—Ligand interactions using electrospray ionization mass spectrometry

  2010cited by this paper
• Nonspecific interactions between proteins and charged biomolecules in electrospray ionization mass spectrometry

  2010cited by this paper
• The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention.

  2010cited by this paper
• The Mycobacterium tuberculosis cytochrome P450 system.

  2010cited by this paper
• Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis

  2009cited by this paper
• Gas-phase unfolding and disassembly reveals stability differences in ligand-bound multiprotein complexes.

  2009cited by this paper
• Cyclodipeptide synthases are a family of tRNA-dependent peptide bond-forming enzymes.

  2009cited by this paper
• The Structure of Mycobacterium tuberculosis CYP125

  2009cited by this paper
• Mycobacterium tuberculosis CYP130

  2008cited by this paper
• Binding constant determination of high-affinity protein-ligand complexes by electrospray ionization mass spectrometry and ligand competition.

  2008cited by this paper
• Characterization of Active Site Structure in CYP121

  2008cited by this paper
• Screening for novel antituberculosis agents that are effective against multidrug resistant tuberculosis.

  2007cited by this paper
• New tuberculosis therapeutics: a growing pipeline.

  2007cited by this paper
• Determining the stoichiometry and interactions of macromolecular assemblies from mass spectrometry

  2007cited by this paper
• Method for stabilizing protein-ligand complexes in nanoelectrospray ionization mass spectrometry.

  2007cited by this paper
• Free energies of protein–protein association determined by electrospray ionization mass spectrometry correlate accurately with values obtained by solution methods

  2006cited by this paper
• Crystal Structure of the Mycobacterium tuberculosis P450 CYP121-Fluconazole Complex Reveals New Azole Drug-P450 Binding Mode*

  2006cited by this paper
• Surface plasmon resonance analysis of antifungal azoles binding to CYP3A4 with kinetic resolution of multiple binding orientations.

  2006cited by this paper
• DMSO-Related Effects in Protein Characterization

  2006cited by this paper
• The potential of azole antifungals against latent/persistent tuberculosis.

  2006cited by this paper
• The preponderance of P450s in the Mycobacterium tuberculosis genome.

  2006cited by this paper
• Investigation of intact protein complexes by mass spectrometry.

  2004cited by this paper
• The 1.92-Å Structure of Streptomyces coelicolor A3(2) CYP154C1

  2003cited by this paper
• Influence of solution and gas phase processes on protein-carbohydrate binding affinities determined by nanoelectrospray Fourier transform ion cyclotron resonance mass spectrometry.

  2003cited by this paper
• Atomic Structure of Mycobacterium tuberculosis CYP121 to 1.06 Å Reveals Novel Features of Cytochrome P450*

  2003cited by this paper
• Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains

  2002cited by this paper
• Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes.

  2002cited by this paper
• Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis.

  2002cited by this paper
• Quantitative determination of noncovalent binding interactions using soft ionization mass spectrometry

  2002cited by this paper
• Stabilization of gas-phase noncovalent macromolecular complexes in electrospray mass spectrometry using aqueous triethylammonium bicarbonate buffer.

  2001cited by this paper
• Erratum: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

  1998cited by this paper
• Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors.

  1969cited by this paper

• Fragment-based drug discovery campaigns guided by native mass spectrometry.

  2024cites this paper
• Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosis

  2021cites this paper
• 19F-NMR reveals substrate specificity of CYP121A1 in Mycobacterium tuberculosis

  2021cites this paper
• Structure-activity relationships of cyclo(L-tyrosyl-L-tyrosine) derivatives binding to Mycobacterium tuberculosis CYP121: iodinated analogues promote shift to high-spin adduct.

  2019cites this paper
• The computational and experimental studies on a 1, 2, 3-triazole compound and its special binding to three kinds of blood proteins

  2019cites this paper
• "Mirror"-like Protein Dimers Stabilized by Local Heterogeneity at Protein Surfaces.

  2019cites this paper
• Sizing Up Protein-Ligand Complexes: The Rise of Structural Mass Spectrometry Approaches in the Pharmaceutical Sciences.

  2017cites this paper
• Heme Iron Catalysis: Contrast to Non-Heme Iron Enzymes

  2017cites this paper
• Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from Mycobacterium tuberculosis proceeds through a catalytic shunt pathway

  2017cites this paper
• Biochemical and drug targeting studies of Mycobacterium tuberculosis cholesterol oxidase P450 enzymes

  2016cites this paper
• Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors

  2016cites this paper
• Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1

  2016cites this paper
• Characterisation of Novel Cytochrome P450-fusion enzymes

  2015cites this paper
• Fragment-based drug discovery and molecular docking in drug design.

  2015cites this paper
• A Ligand-observed Mass Spectrometry Approach Integrated into the Fragment Based Lead Discovery Pipeline

  2015cites this paper
• Molecular interaction study of flavonoid derivative 3d with human serum albumin using multispectroscopic and molecular modeling approach.

  2014cites this paper
• Identification of inhibitors of the antibiotic-resistance target New Delhi metallo-β-lactamase 1 by both nanoelectrospray ionization mass spectrometry and ultrafiltration liquid chromatography/mass spectrometry approaches.

  2013cites this paper